| WHO | EGIR | NCEP | ACE | IDF |
---|---|---|---|---|---|
Prerequisite | DM, IFG, IGT, IR | insulin in top 25% | None | high risk* | WC ≥ 94 cm (men), WC ≥ 80 cm (women)†|
No of criteria | and ≥ 2 of | and ≥ 2 of | ≥ 3 of | and ≥ 2 of | and ≥ 2 of |
Obesity | BMI > 30 and/or WHR > 0.9 (men), WHR > 0.85 (women) | WC ≥ 94 cm (men), WC ≥ 80 cm (women) | WC ≥ 102 cm (men), WC ≥ 88 cm (women) |  |  |
BP (mmHg) | ≥ 140/90 | ≥ 140/90‡ | ≥ 130/85‡ | >130/85 | ≥ 130/85‡ |
HDL-C (mmol/l) | <0.9 (men), <1.0 (women)§ or | <1.0‡§ or | <1.0 (men), <1.3 (women)‡ | <1.0 (men), <1.3 (women) | <1.0 (men), <1.3 (women)‡ |
TG (mmol/l) | ≥ 1.7 | >2.0‡ | ≥ 1.7‡ | >1.7 | >1.7‡ |
Glucose (mmol/l) | ≥ 6.1, IGT | ≥ 6.1 || | ≥ 5.6‡ | ≥ 6.1, IGT || | ≥ 5.6‡ |